Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.

M. G. Kris, R. J. Gralla, M. T. Burke, L. D. Berkowitz, L. D. Marks, D. P. Kelsen, R. T. Heelan

Research output: Contribution to journalArticlepeer-review

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)763-764
Number of pages2
JournalCancer Treatment Reports
Issue number7-8
StatePublished - Jul 1 1987

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this